Study of XL228 Administered Intravenously to Subjects With Advanced Malignancies

This study has been terminated.

( Sponsor decision )

Study NCT00526838 Information provided by Exelixis

First Received: September 6, 2007 Last Updated: April 4, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	June 2011
Estimated Primary Completion Date:	June 2011 (Final data collection date for primary outcome measure)